Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
D000818:Animals; D003352:Corynebacterium / Q000276:immunology*; D003601:Cytotoxicity Tests, Immunologic; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007275:Injections, Intravenous; D008264:Macrophages / Q000276:immunology; D012515:Mast-Cell Sarcoma / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009374:Neoplasms, Experimental / Q000628:therapy; D011425:Propionibacterium acnes / Q000276:immunology*; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy; D013997:Time Factors